State Street’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$100M Sell
3,775,691
-279,727
-7% -$7.41M ﹤0.01% 1315
2025
Q1
$97.9M Sell
4,055,418
-870,072
-18% -$21M ﹤0.01% 1278
2024
Q4
$198M Buy
4,925,490
+251,423
+5% +$10.1M 0.01% 946
2024
Q3
$296M Sell
4,674,067
-448,361
-9% -$28.4M 0.01% 711
2024
Q2
$272M Buy
5,122,428
+1,795,861
+54% +$95.2M 0.01% 707
2024
Q1
$273M Sell
3,326,567
-2,406,423
-42% -$197M 0.01% 720
2023
Q4
$107M Sell
5,732,990
-678,072
-11% -$12.6M 0.01% 1252
2023
Q3
$71M Buy
6,411,062
+1,591,686
+33% +$17.6M ﹤0.01% 1406
2023
Q2
$78.1M Sell
4,819,376
-461,568
-9% -$7.48M ﹤0.01% 1386
2023
Q1
$87.9M Buy
5,280,944
+5,034,102
+2,039% +$83.8M 0.01% 1268
2022
Q4
$2.32M Hold
246,842
﹤0.01% 3327
2022
Q3
$671K Sell
246,842
-14,200
-5% -$38.6K ﹤0.01% 3677
2022
Q2
$754K Sell
261,042
-1,096,134
-81% -$3.17M ﹤0.01% 3694
2022
Q1
$4.07M Sell
1,357,176
-2,768,391
-67% -$8.31M ﹤0.01% 3281
2021
Q4
$19M Buy
4,125,567
+83,316
+2% +$383K ﹤0.01% 2509
2021
Q3
$25.4M Sell
4,042,251
-943,709
-19% -$5.93M ﹤0.01% 2308
2021
Q2
$29.9M Sell
4,985,960
-1,798,484
-27% -$10.8M ﹤0.01% 2229
2021
Q1
$42.9M Buy
6,784,444
+1,711,888
+34% +$10.8M ﹤0.01% 1857
2020
Q4
$28.6M Buy
5,072,556
+14,392
+0.3% +$81K ﹤0.01% 2011
2020
Q3
$29.4M Buy
5,058,164
+781,402
+18% +$4.55M ﹤0.01% 1807
2020
Q2
$30.8M Buy
4,276,762
+634,812
+17% +$4.58M ﹤0.01% 1765
2020
Q1
$17M Buy
3,641,950
+31,688
+0.9% +$148K ﹤0.01% 1945
2019
Q4
$29M Sell
3,610,262
-250,608
-6% -$2.01M ﹤0.01% 1887
2019
Q3
$26.6M Sell
3,860,870
-3,071,555
-44% -$21.1M ﹤0.01% 1876
2019
Q2
$57.5M Sell
6,932,425
-295,463
-4% -$2.45M ﹤0.01% 1391
2019
Q1
$71.8M Buy
7,227,888
+466,403
+7% +$4.64M 0.01% 1230
2018
Q4
$51.7M Buy
6,761,485
+707,934
+12% +$5.42M ﹤0.01% 1326
2018
Q3
$105M Buy
6,053,551
+5,321,983
+727% +$92.7M 0.01% 1042
2018
Q2
$6.94M Buy
731,568
+699,668
+2,193% +$6.64M ﹤0.01% 2701
2018
Q1
$140K Buy
+31,900
New +$140K ﹤0.01% 3590